The New FDA: Product Development, Pricing and Beyond
- Author
- Ropes & Gray LLP
- Published
- Tue 20 Dec 2016
- Episode Link
- https://share.transistor.fm/s/0496cdf0
What impact will the incoming Trump administration have on the 2017 health care and life sciences regulatory outlook? In this podcast, Washington, D.C.-based partners Tom Bulleit (health care) and Al Cacozza (life sciences) offer their perspectives on what might lie ahead.
